NovoCure Past Earnings Performance
Past criteria checks 0/6
NovoCure's earnings have been declining at an average annual rate of -41.4%, while the Medical Equipment industry saw earnings growing at 12.3% annually. Revenues have been growing at an average rate of 14.5% per year.
Key information
-41.4%
Earnings growth rate
-37.7%
EPS growth rate
Medical Equipment Industry Growth | 12.9% |
Revenue growth rate | 14.5% |
Return on equity | -50.1% |
Net Margin | -39.1% |
Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How NovoCure makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 23 | 504 | -197 | 380 | 224 |
30 Jun 23 | 508 | -174 | 354 | 222 |
31 Mar 23 | 522 | -141 | 331 | 224 |
31 Dec 22 | 538 | -93 | 306 | 206 |
30 Sep 22 | 543 | -82 | 289 | 208 |
30 Jun 22 | 545 | -68 | 279 | 204 |
31 Mar 22 | 538 | -59 | 269 | 198 |
31 Dec 21 | 535 | -58 | 263 | 201 |
30 Sep 21 | 546 | -27 | 253 | 188 |
30 Jun 21 | 545 | -5 | 246 | 173 |
31 Mar 21 | 527 | 12 | 232 | 153 |
31 Dec 20 | 494 | 20 | 225 | 132 |
30 Sep 20 | 450 | 19 | 216 | 112 |
30 Jun 20 | 409 | 12 | 206 | 98 |
31 Mar 20 | 380 | 9 | 197 | 87 |
31 Dec 19 | 351 | -7 | 185 | 79 |
30 Sep 19 | 322 | -27 | 174 | 70 |
30 Jun 19 | 294 | -41 | 166 | 65 |
31 Mar 19 | 269 | -55 | 158 | 57 |
31 Dec 18 | 248 | -64 | 151 | 51 |
30 Sep 18 | 232 | -59 | 143 | 46 |
30 Jun 18 | 217 | -59 | 137 | 42 |
31 Mar 18 | 194 | -64 | 131 | 40 |
31 Dec 17 | 177 | -62 | 123 | 38 |
30 Sep 17 | 154 | -73 | 115 | 37 |
30 Jun 17 | 125 | -95 | 112 | 37 |
31 Mar 17 | 105 | -114 | 108 | 39 |
31 Dec 16 | 83 | -132 | 107 | 41 |
30 Sep 16 | 65 | -143 | 108 | 44 |
30 Jun 16 | 52 | -135 | 96 | 44 |
31 Mar 16 | 41 | -124 | 85 | 45 |
31 Dec 15 | 33 | -112 | 73 | 44 |
30 Sep 15 | 25 | -102 | 60 | 44 |
30 Jun 15 | 20 | -94 | 53 | 43 |
31 Mar 15 | 18 | -86 | 49 | 41 |
31 Dec 14 | 15 | -81 | 45 | 40 |
31 Dec 13 | 10 | -77 | 33 | 35 |
Quality Earnings: NVCR N is currently unprofitable.
Growing Profit Margin: NVCR N is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NVCR N is unprofitable, and losses have increased over the past 5 years at a rate of 41.4% per year.
Accelerating Growth: Unable to compare NVCR N's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NVCR N is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-3%).
Return on Equity
High ROE: NVCR N has a negative Return on Equity (-50.11%), as it is currently unprofitable.